We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+19.22%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$329M
AUM Growth
+$48.1M
(+17%)
Cap. Flow
+$13.8M
Cap. Flow
% of AUM
4.19%
Top 10 Holdings %
Top 10 Hldgs %
47.62%
Holding
92
New
27
Increased
14
Reduced
15
Closed
20
Top Buys
| 1 |
Merck
MRK
|
+$14.6M |
| 2 |
Gilead Sciences
GILD
|
+$12.1M |
| 3 |
GSK
GSK
|
+$9.11M |
| 4 |
Sanofi
SNY
|
+$8.01M |
| 5 |
Medtronic
MDT
|
+$7.28M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$18.6M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$8.58M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$7.52M |
| 4 |
Avantor
AVTR
|
+$6.99M |
| 5 |
InMode
INMD
|
+$5.79M |
Sector Composition
| 1 | Healthcare | 92.39% |
| 2 | Financials | 0.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
1
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $19.4M | 5.9% |
185,757
+6,043
| +3% | +$678K |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $18.5M | 5.63% |
96,931
-3,698
| -4% | -$667K |
|
3
Coherus Oncology
CHRS
$225M
| $17M | 5.18% |
946,761
+341,976
| +57% | +$6.31M |
|
|
4
Medtronic
MDT
$103B
| $16.7M | 5.06% |
147,022
+66,320
| +82% | +$7.28M |
|
5
HCA Healthcare
HCA
$81.9B
| $16.2M | 4.92% |
109,599
-25,000
| -19% | -$3.36M |
|
|
6
Merck
MRK
$304B
| $15.4M | 4.69% |
+177,903
| New | +$14.6M |
|
7
Pfizer
PFE
$140B
| $14.9M | 4.53% |
401,441
+99,523
| +33% | +$3.54M |
|
|
WCG
8
DELISTED
Wellcare Health Plans, Inc.
WCG
| $14.8M | 4.51% |
44,935
-5,500
| -11% | -$1.65M |
|
|
9
Gilead Sciences
GILD
$162B
| $12.1M | 3.67% |
+186,000
| New | +$12.1M |
|
10
United Therapeutics
UTHR
$22.3B
| $11.7M | 3.55% |
132,664
+45,000
| +51% | +$3.96M |
|
11
Molina Healthcare
MOH
$12.2B
| $9.94M | 3.02% |
73,236
+40,746
| +125% | +$5.13M |
|
|
12
GSK
GSK
$103B
| $9.62M | 2.92% |
+163,764
| New | +$9.11M |
|
13
McKesson
MCK
$94B
| $9.47M | 2.87% |
68,439
+5,249
| +8% | +$742K |
|
14
Cencora
COR
$58.8B
| $9.46M | 2.87% |
111,249
+8,146
| +8% | +$698K |
|
15
Regeneron Pharmaceuticals
REGN
$69.1B
| $9.3M | 2.82% |
24,776
| – | – |
|
16
Elevance Health
ELV
$85.2B
| $9.28M | 2.82% |
30,739
+3,454
| +13% | +$950K |
|
|
17
Sanofi
SNY
$104B
| $8.58M | 2.61% |
+170,977
| New | +$8.01M |
|
|
BEAT
18
DELISTED
BioTelemetry, Inc.
BEAT
| $7.41M | 2.25% |
160,015
-31,025
| -16% | -$1.34M |
|
|
LITS
19
Lite Strategy Inc
LITS
$34.4M
| $5.95M | 1.81% |
119,943
+107,000
| +827% | +$3.98M |
|
20
Viking Therapeutics
VKTX
$4.38B
| $5.87M | 1.78% |
731,453
-23,306
| -3% | -$170K |
|
21
Immunovant
IMVT
$7.89B
| $5.48M | 1.66% |
+615,400
| New | +$6.89M |
|
22
Merit Medical Systems
MMSI
$4.33B
| $4.68M | 1.42% |
+150,000
| New | +$4.3M |
|
23
Ardelyx
ARDX
$1.25B
| $4.67M | 1.42% |
+621,534
| New | +$3.78M |
|
|
HRC
24
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $4.56M | 1.39% |
40,182
| – | – |
|
|
25
Alnylam Pharmaceuticals
ALNY
$37.5B
| $4.22M | 1.28% |
36,632
-86,021
| -70% | -$8.58M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA